These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 280145)

  • 1. Antiviral activities of 4'-(9-acridinylamino)-methanesulfon-M-aniside (SN11841).
    Byrd DM
    Ann N Y Acad Sci; 1977 Mar; 284():463-71. PubMed ID: 280145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of streptovaricins and their degradation products on infectivity of Rauscher leukemia virus.
    Li LH; Clark TD; Cowie CH; Swenberg JA; Renis HE; Rinehart KL
    J Natl Cancer Inst; 1977 Feb; 58(2):245-9. PubMed ID: 64616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double infection of BALB/c mice with Rauscher murine leukemia and Herpes simplex virus type 2.
    Oleszak E; Inglot AD
    Arch Immunol Ther Exp (Warsz); 1980; 28(2):337-44. PubMed ID: 6255890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Castanospermine vs. its 6-O-butanoyl analog: a comparison of toxicity and antiviral activity in vitro and in vivo.
    Ruprecht RM; Bernard LD; Bronson R; Gama Sosa MA; Mullaney S
    J Acquir Immune Defic Syndr (1988); 1991; 4(1):48-55. PubMed ID: 1984055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral and anticellular effects of synthetic (2'-5')-oligoadenylate (A 2' p 5' A 2' p 5' A) in Rauscher murine leukaemia.
    Kára J; Mach O; Smrt J
    Acta Virol; 1983 Nov; 27(6):477-83. PubMed ID: 6140832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of SKF 108922, an HIV-1 protease inhibitor, on retrovirus replication in mice.
    Black Pl; Ussery MA; Barney S; Wittrock R; DeMarsh P; Dreyer GB; Petteway SR; DalMonte P; Baldoni J; Lambert D
    Antiviral Res; 1996 Mar; 29(2-3):175-86. PubMed ID: 8739597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of RNA tumor virus replication in vitro and evaluation of candidate antiviral agents in vivo.
    Shannon WM
    Ann N Y Acad Sci; 1977 Mar; 284():472-507. PubMed ID: 280146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of Mycoplasma arthritidis and Rauscher leukosis virus on murine peritoneal macrophages in vitro and in vivo].
    Maslova TN; Sanin AV; Khorobrykh VV
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Apr; (4):61-5. PubMed ID: 7080761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased titres of herpes simplex virus in Rauscher leukosis-infected mice.
    Barinsky IF; Tolmacheva VD; Spynu KI
    Acta Virol; 1976 Oct; 20(5):443. PubMed ID: 11676
    [No Abstract]   [Full Text] [Related]  

  • 10. Potentiation of leukemogenicity and infectivity of Rauscher leukemia virus by an enhancing factor present in egg fluids.
    Gazit A; Eylan E; Rosen N; Samucha R
    Exp Cell Biol; 1979; 47(1):29-42. PubMed ID: 437243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tamoxifen, droloxifene and 17 beta-estradiol on Rauscher mouse leukemogenesis.
    Sydow G; Wunderlich V
    Cancer Lett; 1994 Jul; 82(1):89-94. PubMed ID: 8033074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by streptovaricins of Rauscher leukemia virus splenomegaly.
    Borden EC; Carter WA; Sensenbrenner LL; Owens AH; Lichtenstein J; Gray GD; Neil GL; Nichol FR; Li LH
    Int J Cancer; 1974 Dec; 14(6):817-25. PubMed ID: 4156850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo analysis of castanospermine, a candidate antiretroviral agent.
    Ruprecht RM; Mullaney S; Andersen J; Bronson R
    J Acquir Immune Defic Syndr (1988); 1989; 2(2):149-57. PubMed ID: 2495348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lead aggravates viral disease and represses the antiviral activity of interferon inducers.
    Gainer JH
    Environ Health Perspect; 1974 May; 7():113-9. PubMed ID: 4364644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of Trichinella spiralis infection on the development of Rauscher leukemia].
    Trubcheninova LP; Chimishkian KL; Ovutian GSh; Babichev VA; Svet-Moldavskiĭ GIa
    Vopr Virusol; 1975; (3):344-8. PubMed ID: 1162955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin responses and physical characterization of erythroid progenitor cells in Rauscher virus infected BALB/c mice.
    Hasthorpe S; Bol S
    J Cell Physiol; 1979 Jul; 100(1):77-86. PubMed ID: 468921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antileukemic activity of Viva-Natural, a dietary seaweed extract, on Rauscher murine leukemia in comparison with anti-HIV agents, azidothymidine, dextran sulfate and pentosan polysulfate.
    Furusawa E; Furusawa S; Chou SC
    Cancer Lett; 1991 Mar; 56(3):197-205. PubMed ID: 1708693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase 1 clinical investigation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992), a new acridine derivative.
    Legha SS; Gutterman JU; Hall SW; Benjamin RS; Burgess MA; Valdivieso M; Bodey GP
    Cancer Res; 1978 Nov; 38(11 Pt 1):3712-6. PubMed ID: 279397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulopoiesis in "preleukemic" mice with anemia induced by Rauscher leukemia virus, variant a.
    Broxmeyer HE; Koltun L; LoBue J; Fredrickson TN; Gordon AS
    J Natl Cancer Inst; 1975 Nov; 55(5):1123-7. PubMed ID: 1107569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressive effect of immunization with mouse fetal antigens on growth of cells infected with Rauscher leukemia virus and plasma-cell tumors.
    Hanna MG; Tennant RW; Coggin JH
    Proc Natl Acad Sci U S A; 1971 Aug; 68(8):1748-52. PubMed ID: 4942913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.